188 related articles for article (PubMed ID: 31923372)
1. Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.
Akel RA; Guo XM; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Tanner Iii EJ; Pavone ME
J Adolesc Young Adult Oncol; 2020 Jun; 9(3):367-374. PubMed ID: 31923372
[No Abstract] [Full Text] [Related]
2. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population.
Manuel SL; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Pavone ME
J Assist Reprod Genet; 2020 Mar; 37(3):699-708. PubMed ID: 31828481
[TBL] [Abstract][Full Text] [Related]
6. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
7. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
9. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
10. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.
Goldrat O; Van Den Steen G; Gonzalez-Merino E; Dechène J; Gervy C; Delbaere A; Devreker F; De Maertelaer V; Demeestere I
Reprod Biol Endocrinol; 2019 Jan; 17(1):3. PubMed ID: 30606204
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes.
Tsonis O; Kopeika J
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():93-100. PubMed ID: 37757729
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Smith KN; Kazer RR; Klock SC; Lawson AK; Gradishar WJ; Pavone ME
Fertil Steril; 2018 Feb; 109(2):349-355. PubMed ID: 29338854
[TBL] [Abstract][Full Text] [Related]
13. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
[TBL] [Abstract][Full Text] [Related]
14. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
15. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
[TBL] [Abstract][Full Text] [Related]
16. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
17. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
18. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
20. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
